InstituteOfScience.com

Copyright 1995-2001 S.H. Shakman, Institute Of Science; all rights reserved.

PLEASE PAY PER VIEW. THANK YOU.
Amazon Honor System

The AUTOMEDICAL INDEX

by Stuart Hale Shakman; Copyright 1995,1996

OVERVIEW

This AUTOMEDICAL INDEX is a compilation of excerpts and bibliographies from three categories of medical references:
- - "autohemotherapy" - reinjection of autologous blood or serum. Selected excerpts from the historical literature; a full bibliography (963 citations) from the late 19th century through 1982, when the parent "serotherapy" category was eliminated from the printed INDEX MEDICUS, augmented by "autohemotherapy" references from 1966 found in MEDLINE.
- - "autogenous vaccines" - vaccines generated from the individual patient. A full bibliography of the historical literature (345 citations) from the early 20th century through 1982, when the parent "vaccine-therapy" category was eliminated from the printed INDEX MEDICUS.
- - E. C. Rosenow's works, involving autogenous vaccines and oral foci of infection, etc. Selected excerpts and a full bibliography (293 citations, from 1902 through 1958 and 1966 obituary). Dr. Rosenow's work is augmented with a compilation of selected excerpts on the subject of oral focal infections.

Table 1 lists numbers of citations by year by category (autohemotherapy, autovaccines, Rosenow), illustrating their popularity within a common time frame.

Table 2 lists diseases addressed by combinations of these three categories, illustrating a suggested underlying substantive relationship, as discussed below.

. This research project evolved from a report that Dr.Eutiquiano Cuyugan had successfully used intramuscularly-reinjected autoblood to treat malaria during World War II, and his son Roberto's suggestion that the procedure might be useful against other diseases such as AIDS. [See "Cuyugan's Malaria Treatment; Aid vs AIDS?"] This procedure has historically been known as "autohemotherapy".

Autohemotherapy, the reinjection of one's own blood, has reportedly been used successfully to treat a wide range of disease conditions. As originally described by Ravaut [: ANN. DE DERM. ET SYPH. 4 (May 1913), p. 292], autohemotherapy involved the prompt intramuscular reinjection of up to 20 cc of autologous blood. Common practice in subsequent years involved repeated injections of up to 10cc, administered on a weekly or bi-weekly basis. Results in some conditions have been reported as having "often been spectacular".

While some older American dermatologists and allergists continue to refer to and use this simple "classical" form of autohemotherapy, the practice is more common in some European countries, notably Germany and Russia. At the same time it is noted that (a) numerous articles discussing the subcutaneous or intramuscular reinjection of autoblood may be found in the current medical literature through MEDLINE using alternate keywords, such as "subcutaneous autologous blood therapy", etc; and (b) the term "autohemotherapy" continues to be used with reference to reinjected autologous blood, e.g., a form of intravenous autohemotherapy (in conjunction with exposure to ozone) has been proposed for AIDS by [Bocci in 1992]. This supports Cuyugan's earlier suggestion, as noted above, that the historically-more- common and far less-costly extravascular form of autohemotherapy be used as therapy by persons infected with HIV. In addition, the wide-ranging applicability and proven safety of extravascular autohemotherapy argue strongly for its adoption as a treatment of immediate first resort in mysterious, newly emerging and other infectious conditions thought to be disseminated through the bloodstream.

Autogenous vaccines are made from a suspected causative organism taken from and administered to the same patient. Autohemotherapy and autogenous vaccines are often associated with many of the same disease conditions, supporting the view that the underlying action of autohemotherapy may at least in part be that of a therapeutic vaccine.

Dr. E.C. Rosenow, the Mayo Clinic's Head of Experimental Bacteriology from 1915-1944, reportedly worked miracles with autogenous vaccines in a wide range of disease conditions, many of which have also independently been reported as yielding to autohemotherapy. In many of these conditions, Dr. Rosenow established the presence of an organism or its harmful products in the blood during active stages of disease, thus providing support to the view that autohemotherapy to some extent may comprise a form of vaccine- therapy. Dr. Rosenow administered vaccines on a bi-weekly basis [e.g., see 58R1].

Dr. Rosenow and several other investigators demonstrated that the offending organism in many disease conditons had emanated from oral foci of infection, primarily diseased or nonvital teeth, and consistently replicated a wide range of systemic disease conditions in laboratory animals with organisms from these oral foci.

LIMITATIONS:
It is noted that although Dr. Rosenow first used "autogenous vaccine therapy" in an article title in 1910 [10R4] and was a prominent advocate of vaccine-therapy, none of his nearly 300 articles are listed in the INDEX MEDICUS under "vaccine-therapy". It may therefore be assumed that other authors who used autogenous- vaccine-therapy have similarly been inadvertently excluded from the "vaccine-therapy" category, and likewise for "autohemotherapy"; thus The AUTOMEDICAL INDEX is properly viewed as a core, but not all-inclusive, listing of articles on these subjects.

No attempt has been made to comprehensively correlate the field of focal infection with autohemotherapy, except as indicated by direct correlation between Dr. Rosenow's work and autohemotherapy as in Table 2.

ON NOMENCLATURE:
THE AUTOMEDICAL INDEX essentially preserves the nomenclature of original listings; thus some separate disease entries may actually refer to identical diseases; some cross-references are provided, but these are by no means comprehensive. The reader is encouraged to employ synomyms in searches.